Evidence map›Paper›PMID 36271118›Full record

ArticleScientific reports2022

Different antibody-associated autoimmune diseases have distinct patterns of T follicular cell dysregulation.

Filipa Ribeiro, Vasco C Romão, Sara Rosa, Kátia Jesus, Ana Água-Doce, Sofia C Barreira, Patrícia Martins, Susana Lopes da Silva, Ema Nobre, Maria João Bugalho and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Gut-joint axis: Gut dysbiosis can contribute to the onset of rheumatoid arthritisFrontiers in cellular and infection microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Filipa Ribeiro *Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon Academic Medical Centre, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.
Vasco C Romão *Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon Academic Medical Centre, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.
Sara RosaInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon Academic Medical Centre, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.
Kátia JesusInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon Academic Medical Centre, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.
Ana Água-DoceInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon Academic Medical Centre, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.
Sofia C BarreiraInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon Academic Medical Centre, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.
Patrícia MartinsInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon Academic Medical Centre, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.
Susana Lopes da SilvaInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon Academic Medical Centre, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.
Ema NobreRheumatology Department, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon Academic Medical Centre, Lisboa, Portugal.
Maria João BugalhoRheumatology Department, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon Academic Medical Centre, Lisboa, Portugal.
Válter R FonsecaInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon Academic Medical Centre, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.
João Eurico FonsecaInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon Academic Medical Centre, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.
Luis GracaInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisbon Academic Medical Centre, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal. lgraca@medicina.ulisboa.pt.
University of Lisbon · PTHospital de Santa Maria · PTCentro Hospitalar Lisboa Norte · PTInstituto Gulbenkian de Ciência · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoantibodies are produced within germinal centers (GC), in a process regulated by interactions between B, T follicular helper (Tfh), and T follicular regulatory (Tfr) cells. The GC dysregulation in human autoimmunity has been inferred from circulating cells, albeit with conflicting results due to diverse experimental approaches. We applied a consistent approach to compare circulating Tfr and Tfh subsets in patients with different autoimmune diseases. We recruited 97 participants, including 72 patients with Hashimoto's thyroiditis (HT, n = 18), rheumatoid arthritis (RA, n = 16), or systemic lupus erythematosus (SLE, n = 32), and 31 matched healthy donors (HD). We found that the frequency of circulating T follicular subsets differed across diseases. Patients with HT had an increased frequency of blood Tfh cells (p = 0.0215) and a reduced Tfr/Tfh ratio (p = 0.0338) when compared with HD. This was not observed in patients with systemic autoimmune rheumatic diseases (RA, SLE), who had a reduction in both Tfh (p = 0.0494 and p = 0.0392, respectively) and Tfr (p = 0.0003 and p = 0.0001, respectively) cells, resulting in an unchanged Tfr/Tfh ratio. Activated PD-1

Indexed as

Hashimoto DiseaseLupus Erythematosus, SystemicAutoantibodiesHumansProgrammed Cell Death 1 ReceptorT-Lymphocytes, Helper-InducerT-Lymphocytes, RegulatoryAutoantibodiesProgrammed Cell Death 1 Receptor

Identifiers

PMID36271118
PMCPMC9587230
OpenAlexW4306983474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.